Tonix Pharmaceuticals stock halted ahead of FDA approval news
REDWOOD CITY, Calif. - C3 AI (NYSE:AI), a $2.27 billion market cap enterprise AI software company showing strong revenue growth of 25% year-over-year, announced on Tuesday the release of C3 Agentic AI Websites, a new product designed to transform standard websites into interactive, conversational platforms. According to InvestingPro data, the company maintains a solid financial position with more cash than debt on its balance sheet.
The solution, which is already implemented on C3 AI’s own website, allows visitors to ask questions directly about a company and receive immediate responses synthesized from content across the site’s ecosystem, including product pages, case studies, documents, and videos. While the company’s stock has experienced significant volatility, trading at $16.91 against a 52-week range of $14.70 to $45.08, InvestingPro analysis indicates the stock may be undervalued at current levels.
According to the company’s press release, the product processes queries and delivers responses drawn from an enterprise’s website content, eliminating the need for users to navigate through multiple pages to find information.
"We’ve built a smarter way for people to find what they’re looking for, making every website more intelligent, more helpful, and more aligned with how people actually want to interact with information on the web," said Nikhil Krishnan, CTO, Data Science at C3 AI.
The company states that the solution is powered by proprietary content parsing and generative AI architecture, designed to optimize customer journeys and accelerate engagement and conversion.
C3 Agentic AI Websites is available immediately, with the company offering a 30-day free trial followed by an annual fee of $150,000 for full production.
Cerebras Systems, a technology partner for the product, provides AI inference capabilities to support the solution. "Our technology helps ensure that C3 Agentic AI Websites delivers fast, responsive experiences at scale," said Andy Hock, SVP, Product & Strategy at Cerebras Systems.
C3 AI describes itself as an Enterprise AI application software company that provides an end-to-end platform for developing and operating enterprise AI applications, along with industry-specific SaaS solutions. The company maintains a healthy current ratio of 6.86, indicating strong liquidity to meet short-term obligations. For deeper insights into C3 AI’s financial health and growth prospects, investors can access comprehensive analysis through InvestingPro, which offers 10+ additional exclusive ProTips and detailed financial metrics.
In other recent news, C3.ai has faced significant challenges with its preliminary first-quarter fiscal 2026 results, reporting revenue of $70.3 million. This figure marks a 19% year-over-year decline and falls considerably short of the company’s earlier guidance of $104.5 million, which had anticipated 20% growth. In response to this revenue shortfall, Oppenheimer downgraded C3.ai from Outperform to Perform, removing its previous price target of $45. Similarly, Northland downgraded the stock to Market Perform, setting a price target of $17.00 due to missed revenue expectations, particularly in subscription revenues. UBS also adjusted its price target for C3.ai, lowering it from $27.00 to $23.00 while maintaining a Neutral rating. Wedbush followed suit by reducing its price target from $35.00 to $23.00, citing a challenging quarter for the company. Amid these financial adjustments, C3.ai announced the launch of its Strategic Integrator Program, allowing partners to license its Enterprise AI platform for developing and marketing their own AI applications. This initiative aims to expand C3.ai’s reach by providing partners with intellectual property rights and access to developer resources.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.